Key statistics
As of last trade, Uniqure NV (UQ1:FRA) traded at 17.36, 140.64% above the 52 week low of 7.21 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 17.36 |
|---|---|
| High | 17.36 |
| Low | 17.36 |
| Bid | 17.60 |
| Offer | 18.00 |
| Previous close | 18.96 |
| Average volume | 757.00 |
|---|---|
| Shares outstanding | 62.29m |
| Free float | 58.95m |
| P/E (TTM) | -- |
| Market cap | 1.28bn USD |
| EPS (TTM) | -4.39 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 07:14 GMT.
More ▼
- uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
- uniQure Announces Type A Meeting Scheduled with FDA
- uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
- uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update
- uniQure to Announce Third Quarter 2025 Financial Results
- uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
- uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
- uniQure Announces Pricing of Upsized $300 Million Public Offering
- uniQure Announces $200 Million Proposed Public Offering
- uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding
More ▼
